Recombinant adenovirus-mediated p14ARF overexpression sensitizes human breast cancer cells to cisplatin

Biochemical and Biophysical Research Communications

Volumn 296, Issue 4, 2002, Pages 792-798

  Deng, Xiyun ^a,b   Kim, Min ^a,c   Vandier, Didier ^a   Jung, Yun jin ^a   Rikiyama, Toshiki ^a   Sgagias, Magda K ^a   Goldsmith, Merrill ^a   Cowan, Kenneth H ^a,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Central South University   (China)

^c NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Breast cancer; Cisplatin; Gene therapy; P14ARF; Recombinant adenovirus

Indexed keywords

CISPLATIN; PACLITAXEL; PROTEIN P14;

ADENOVIRUS; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CELL COUNT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MITOSIS; MITOSIS INHIBITION; NICK END LABELING; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ADENOVIRIDAE; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL CYCLE; CELL LINE; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENES, P53; HUMANS; IN SITU NICK-END LABELING; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

ADENOVIRIDAE; MINK CELL FOCUS-FORMING VIRUS;

EID: 0036385406     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00948-8     Document Type: Article

References (34)

1. M. Serrano, H. Lee, L. Chin, C. Cordon-Cardo, D. Beach, R.A. DePinho, Role of the INK4a locus in tumor suppression and cell mortality, Cell 85 (1996) 27-37.
2. T. Kamijo, F. Zindy, M.F. Roussel, D.E. Quelle, J.R. Downing, R.A. Ashmun, G. Grosveld, C.J. Sherr, Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF, Cell 91 (1997) 649-659.
3. C.J. Sherr, The Pezcoller lecture: cancer cell cycles revisited, Cancer Res. 60 (2000) 3689-3695.
4. C.J. Sherr, The INK4a/ARF network in tumour suppression, Nat. Rev. Mol. Cell. Biol. 2 (2001) 731-737.
5. S. Bates, A.C. Phillips, P.A. Clarke, F. Stott, G. Peters, R.L. Ludwig, K.H. Vousden, p14ARF links the tumor suppressors pRB and p53, Nature 395 (1998) 124-125.
6. Y. Zhang, Y. Xiong, W.G. Yarbrough, ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways, Cell 92(1998) 725-734.
7. J. Pomerantz, N. Schreiber-Agus, N.J. Liegeois, A. Silverman, L. Alland, L. Chin, J. Potes, K. Chen, I. Orlow, H.W. Lee, C. Cordon-Cardo, R.A. DePinho, The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53, Cell 92 (1998) 713-723.
8. M. Serrano, The INK4a/ARF locus in murine tumorigenesis, Carcinogenesis 21 (2000) 865-869.
9. R. Inoue, C. Asker, U. Klangby, P. Pisa, K.G. Wiman, Induction of the human ARF protein by serum starvation, Anticancer Res.
10. D.E. Quelle, F. Zindy, R.A. Ashmun, C.J. Sherr, Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest, Cell 83 (1995) 993-1000.
11. H.O. Weber, T. Samuel, P. Rauch, J.O. Funk, Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways, Oncogene 21 (2002) 3207-3212.
12. A. Radfar, I. Unnikrishnan, H.W. Lee, R.A. DePinho, N. Rosenberg, p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation, Proc. Natl. Acad. Sci. USA 95 (1998) 13194-13199.
13. C.T. Yang, L. You, C.C. Yeh, J.W. Chang, F. Zhang, F. McCormick, D.M. Jablons, Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells, J. Natl. Cancer Inst. 92 (2000) 636-641.
14. P.G. Hemmati, B. Gillissen, C. Von Haefen, J. Wendt, L. Starck, D. Guner, B. Dorken, P.T. Daniel, Adenovirus-mediated overex-pression of p14(ARF) induces p53 and Bax-independent apopto-sis, Oncogene 21 (2002) 3149-3161.
15. K. Tsuji, K. Mizumoto, H. Sudo, K. Kouyama, E. Ogata, M. Matsuoka, p53-Independent apoptosis is induced by the p19(ARF) tumor suppressor, Biochem. Biophys. Res. Commun. 295 (2002) 621-629.
16. C.A. Schmitt, M.E. McCurrach, E. de Stanchina, R.R. Wallace-Brodeur, S.W. Lowe, INK4a/ARF mutations accelerate lympho-magenesis and promote chemoresistance by disabling p53, Genes Dev. 13 (1999) 2670-2677.
17. J.V. Lacey Jr., S.S. Devesa, L.A. Brinton, Recent trends in breast cancer incidence and mortality, Environ. Mol. Mutagen. 39 (2002) 82-88.
18. Y. Katayose, M. Kim, A.N. Rakkar, Z. Li, K.H. Cowan, P. Seth, Promoting apoptosis: a novel activity associated with the cyclin-dependent kinase inhibitor p27, Cancer Res. 57 (1997) 5441-5445.
19. F.J. Stott, S. Bates, M.C. James, B.B. McConnell, M. Starborg, S. Brookes, I. Palmero, K. Ryan, E. Hara, K.H. Vousden, G. Peters, The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2, EMBO J. 17 (1998) 5001-5014.
20. D. Katayose, J. Gudas, H. Nguyen, S. Srivastava, K.H. Cowan, P. Seth, Cytotoxic effects of adenovirus-mediated wt p53 protein expression in normal and tumor mammary epithelial cells, Clin. Cancer Res. 1 (1995) 889-897.
21. C. Craig, M. Kim, E. Ohri, R. Wersto, D. Katayose, Z. Li, Y.H. Choi, B. Mudahar, S. Srivastava, P. Seth, K. Cowan, Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells, Oncogene 16 (1998) 265-272.
22. D. Katayose, R. Wersto, K.H. Cowan, P. Seth, Effects of a recombinant adenovirus expressing WAF1/Cip1 on cell growth, cell cycle, and apoptosis, Cell. Growth Differ. 6 (1995) 1207-1212.
23. C. Craig, R. Wersto, M. Kim, E. Ohri, Z. Li, D. Katayose, S.J. Lee, J. Trepel, K. Cowan, P. Seth, A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells, Oncogene 14 (1997) 2283-2289.
24. S.S. Bacus, A.V. Gudkov, M. Lowe, L. Lyass, Y. Yung, A.P. Komarov, K. Keyomarsi, Y. Yarden, R. Seger, Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53, Oncogene 20 (2001) 147-155.
25. C.J. Sherr, Tumor surveillance via the ARF-p53 pathway, Genes Dev. 12 (1998) 2984-2991.
26. X. Jin, D. Nguyen, W.W. Zhang, A.P. Kyritsis, J.A. Roth, Cell cycle arrest and inhibition of tumor cell proliferation by the p16INK4 gene mediated by an adenovirus vector, Cancer Res. 55 (1995) 3250-3253.
27. V. Sandig, K. Brand, S. Herwig, J. Lukas, J. Bartek, M. Strauss, Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death, Nat. Med. 3 (1997) 313-319.
28. S.P. Frizelle, J. Grim, J. Zhou, P. Gupta, D.T. Curiel, J. Geradts, R.A. Kratzke, Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regression, Oncogene 16 (1998) 3087-3095.
29. R.U. Janicke, M.L. Sprengart, M.R. Wati, A.G. Porter, Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis, J. Biol. Chem. 273 (1998) 9357-9360.
30. M.M. Mc Gee, E. Hyland, G. Campiani, A. Ramunno, V. Nacci, D.M. Zisterer, Caspase-3 is not essential for DNA fragmentation in MCF-7 cells during apoptosis induced by the pyrrolo-1,5-benzoxazepine, PBOX-6, FEBS Lett. 515 (2002) 66-70.
31. W. Lu, J. Lin, J. Chen, Expression of p14ARF overcomes tumor resistance to p53, Cancer Res. 62 (2002) 1305-1310.
32. I. Nasz, E. Adam, Recombinant adenovirus vectors for gene therapy and clinical trials, Acta Microbiol. Immunol. Hung. 48 (2001) 323-348.
33. M.K. Kuhlmann, G. Burkhardt, H. Kohler, Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application, Nephrol. Dial. Transplant. 12 (1997) 2478-2480.
34. I.E. Smith, D.C. Talbot, Cisplatin and its analogues in the treatment of advanced breast cancer: a review, Br. J. Cancer 65 (1992) 787-793.